Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women
- 1 June 2006
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 65 (1), 81-87
- https://doi.org/10.1111/j.1365-2265.2006.02552.x
Abstract
Objective Glucocorticoid hyperactivity in adipose tissue, due to up‐regulation of local glucocorticoid reactivation by 11β‐hydroxysteroid dehydrogenase‐1 (11HSD1) or of glucocorticoid receptors (GR), may underpin susceptibility to the metabolic syndrome. This hypothesis has been tested extensively in subcutaneous adipose tissue (SAT) but inadequately in visceral adipose tissue (VAT). The aim of the study was therefore to examine expression of 11HSD1, GRα and hexose‐6‐phosphate dehydrogenase (H6PDH), which supplies cofactor for 11HSD1, in abdominal adipose tissue compartments and to characterize their relation to metabolic syndrome parameters. Design and subjects A cross‐sectional study including 26 premenopausal South African women. Measurements Biopsies were taken for measurement of mRNA levels by real‐time polymerase chain reaction (RT‐PCR) and 11HSD1 activity from VAT, and deep and superficial SAT compartments during elective surgery. Prior to surgery, blood pressure, blood lipid profile, body composition [by dual X‐ray absorptiometry (DEXA) scan], body fat distribution [by computed tomography (CT) scan], and glucose tolerance were determined. Results 11HSD1 activity (P < 0·01) was higher in VAT than SAT, but 11HSD1 and GRα mRNA levels were not statistically different between compartments. 11HSD1 mRNA levels in superficial SAT correlated with VAT volume (R = 0·57, P < 0·01), insulin sensitivity calculated from the oral glucose tolerance test (OGTT) (R = –0·52, P < 0·016) and blood pressure (R = 0·48, P < 0·016). Apart from a correlation between deep SAT 11HSD1 activity and blood pressure (R = 0·72, P < 0·01), glucocorticoid action in deep SAT and VAT depots was not significantly associated with any metabolic syndrome parameters. Conclusion Increased capacity for glucocorticoid regeneration in superficial SAT but not VAT is associated with visceral adiposity and other features of the metabolic syndrome in women.Keywords
This publication has 41 references indexed in Scilit:
- Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose TissueRecent Progress in Hormone Research, 2004
- Effects of Free Fatty Acids (FFA) on Glucose Metabolism: Significance for Insulin Resistance and Type 2 DiabetesExperimental and Clinical Endocrinology & Diabetes, 2003
- Expression of the mRNA Coding for 11 -Hydroxysteroid Dehydrogenase Type 1 in Adipose Tissue from Obese Patients: An in Situ Hybridization StudyJournal of Clinical Endocrinology & Metabolism, 2002
- A Transgenic Model of Visceral Obesity and the Metabolic SyndromeScience, 2001
- Cortisol increases gluconeogenesis in humans: its role in the metabolic syndromeClinical Science, 2001
- Increments in insulin sensitivity during intensive treatment are closely correlated with decrements in glucocorticoid receptor mRNA in skeletal muscle from patients with Type II diabetesClinical Science, 2001
- Insulin attenuates the stimulatory effects of tumor necrosis factor α on 11β-hydroxysteroid dehydrogenase 1 in human adipose stromal cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2000
- Understanding the Role of Glucocorticoids in Obesity: Tissue-Specific Alterations of Corticosterone Metabolism in Obese Zucker RatsEndocrinology, 2000
- 11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta- reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulationsEndocrinology, 1995
- Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humansJCI Insight, 1970